Data Exclusivity: Is there a happy medium?
In the complex world of pharmaceutical development and regulation, few topics spark as much debate as drug data exclusivity. This […]
In the complex world of pharmaceutical development and regulation, few topics spark as much debate as drug data exclusivity. This […]
1. Introduction to Patent Linkage In the complex world of pharmaceutical innovation and access, patent linkage has emerged as a
Patent linkage: Balancing patent protection and generic entry Read Post »
I. Introduction When it comes to medications, we often find ourselves at a crossroads: should we opt for the brand-name
Are Generic Drugs Less Safe than their Branded Equivalents? Read Post »
I. Introduction to Patents In today’s fast-paced world of innovation and technological advancement, patents play a crucial role in protecting
I. Introduction In the ever-evolving landscape of the pharmaceutical industry, emerging markets have become a focal point for growth and
Finding Generic Drug Entry Opportunities in Emerging Markets Read Post »
In the ever-evolving landscape of pharmaceuticals, biosimilars have emerged as game-changers. But with their rise comes a unique challenge: how
Biosimilar Naming: Navigating the Complex World of Biological Lookalikes Read Post »
Thank you for your interest in submitting a guest article! Submit your guest article here DrugPatentWatch is interested in sharing
Hermann A. M. Mucke*, H. M. Pharma Consultancy, Wien, Austria A Multimodal Approach to the Re-development of Drugs Drug repositioning—the
Drug Repositioning in the Mirror of Patenting: Surveying and Mining Uncharted Territory Read Post »
Share your expertise with our expansive network > Go to submission form < Do you want to reach a large
Get fresh news and insights, drug patent expirations & more…